These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21516074)

  • 1. Clinical applicability of coronary atherosclerotic lesion characterization.
    Kaluski E; Waller A; Patel A; Gerula C; Maher J; Haider B; Klapholz M
    Minerva Cardioangiol; 2011 Jun; 59(3):255-70. PubMed ID: 21516074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
    Naghavi M; Libby P; Falk E; Casscells SW; Litovsky S; Rumberger J; Badimon JJ; Stefanadis C; Moreno P; Pasterkamp G; Fayad Z; Stone PH; Waxman S; Raggi P; Madjid M; Zarrabi A; Burke A; Yuan C; Fitzgerald PJ; Siscovick DS; de Korte CL; Aikawa M; Airaksinen KE; Assmann G; Becker CR; Chesebro JH; Farb A; Galis ZS; Jackson C; Jang IK; Koenig W; Lodder RA; March K; Demirovic J; Navab M; Priori SG; Rekhter MD; Bahr R; Grundy SM; Mehran R; Colombo A; Boerwinkle E; Ballantyne C; Insull W; Schwartz RS; Vogel R; Serruys PW; Hansson GK; Faxon DP; Kaul S; Drexler H; Greenland P; Muller JE; Virmani R; Ridker PM; Zipes DP; Shah PK; Willerson JT
    Circulation; 2003 Oct; 108(15):1772-8. PubMed ID: 14557340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
    Naghavi M; Libby P; Falk E; Casscells SW; Litovsky S; Rumberger J; Badimon JJ; Stefanadis C; Moreno P; Pasterkamp G; Fayad Z; Stone PH; Waxman S; Raggi P; Madjid M; Zarrabi A; Burke A; Yuan C; Fitzgerald PJ; Siscovick DS; de Korte CL; Aikawa M; Juhani Airaksinen KE; Assmann G; Becker CR; Chesebro JH; Farb A; Galis ZS; Jackson C; Jang IK; Koenig W; Lodder RA; March K; Demirovic J; Navab M; Priori SG; Rekhter MD; Bahr R; Grundy SM; Mehran R; Colombo A; Boerwinkle E; Ballantyne C; Insull W; Schwartz RS; Vogel R; Serruys PW; Hansson GK; Faxon DP; Kaul S; Drexler H; Greenland P; Muller JE; Virmani R; Ridker PM; Zipes DP; Shah PK; Willerson JT
    Circulation; 2003 Oct; 108(14):1664-72. PubMed ID: 14530185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do plaques rapidly progress prior to myocardial infarction? The interplay between plaque vulnerability and progression.
    Ahmadi A; Leipsic J; Blankstein R; Taylor C; Hecht H; Stone GW; Narula J
    Circ Res; 2015 Jun; 117(1):99-104. PubMed ID: 26089367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulnerable plaque intervention: State of the art.
    Young JJ; Phillips HR; Marso SP; Granada JF; McPherson JA; Waksman R; Steinhubl SR; Schwartz RS; Stone GW
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):367-74. PubMed ID: 18288729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study.
    Ferrante G; Nakano M; Prati F; Niccoli G; Mallus MT; Ramazzotti V; Montone RA; Kolodgie FD; Virmani R; Crea F
    Circulation; 2010 Dec; 122(24):2505-13. PubMed ID: 21126969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter by Schindhelm regarding article, "High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study".
    Schindhelm RK
    Circulation; 2011 Jul; 124(4):e143; author reply e144. PubMed ID: 21788597
    [No Abstract]   [Full Text] [Related]  

  • 10. [New insights towards catheter-based identification of vulnerable plaque].
    Rodríguez-Granillo GA; Regar E; Schaar JA; Serruys PW
    Rev Esp Cardiol; 2005 Oct; 58(10):1197-206. PubMed ID: 16238988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concept of vulnerable/unstable plaque.
    Finn AV; Nakano M; Narula J; Kolodgie FD; Virmani R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1282-92. PubMed ID: 20554950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From the single vulnerable plaque, to the multiple complex coronary plaques. From their basis, to the modern therapeutic approach. A clinical reality in the spectrum of the acute coronary syndromes].
    Lupi Herrera E; Chuquiure Valenzuela E; Gaspar J; Férez Santander SM
    Arch Cardiol Mex; 2006; 76 Suppl 1():S6-34. PubMed ID: 16830832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
    Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
    Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arithmetic of vulnerable plaques for noninvasive imaging.
    Narula J; Garg P; Achenbach S; Motoyama S; Virmani R; Strauss HW
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5 Suppl 2():S2-10. PubMed ID: 18641603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty.
    Tarantini G; Napodano M; Gasparetto N; Favaretto E; Marra MP; Cacciavillani L; Bilato C; Osto E; Cademartiri F; Musumeci G; Corbetti F; Razzolini R; Iliceto S
    Coron Artery Dis; 2010 Mar; 21(2):78-86. PubMed ID: 20071979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery imaging in the new millennium.
    Worthley SG; Farouque HM; Helft G; Meredith IT
    Heart Lung Circ; 2002; 11(1):19-25. PubMed ID: 16352064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The three mechanisms for coronary artery disease progression: insights into future management.
    McLaughlin MA; Fuster V
    Mt Sinai J Med; 1995 Sep; 62(4):265-74. PubMed ID: 7565849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside.
    Xu X; Li Z; Gao W
    Biomarkers; 2011 Sep; 16(6):466-75. PubMed ID: 21718220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.